Rural Communities Opioid Response Program-Implementation
Description
The Rural Communities Opioid Response Program (RCORP) is a multi-year initiative by the Health Resources and Services Administration (HRSA) aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in high risk rural communities. This notice announces the opportunity to apply for funding under RCORP-Implementation. This funding opportunity, RCORP-Implementation, will advance RCORP’s overall goal by strengthening and expanding SUD/OUD prevention, treatment, and recovery services to enhance rural residents’ ability to access treatment and move towards recovery. Given the complex and multifaceted nature of SUD/OUD, as well as the need to secure community buy-in and generate adequate patient volume to sustain services, HRSA requires that applicants be part of broad, multi-sectoral consortia. HRSA expects that consortia funded by RCORP-Implementation will sustain the SUD/OUD-related services in rural areas made possible by this funding opportunity both during and beyond the period of performance. The target population for the award is: 1) individuals who are at risk for, have been diagnosed with, and/or are in treatment and/or recovery for OUD; 2) their families and/or caregivers; and 3) other community members1 who reside in HRSA-designated rural areas, as defined by the Rural Health Grants Eligibility Analyzer. In addition to this target population, applicants are encouraged to give special consideration to rural populations that have historically suffered from poorer health outcomes or health disparities, as compared to the rest of the rural population. The primary focus of the RCORP-Implementation award program is OUD. However, recognizing that many individuals with OUD use multiple substance and/or have other co-occurring conditions, consortia may also use RCORP-Implementation support to help address other SUD-related needs of the target population of individuals and families affected by OUD. Applicants should link any additional activities they propose to the needs of their target population and service area. Please note that no competitive advantage, funding priority, or preference is associated with proposing activities beyond the core/required activities outlined in the Program-Specific Instructions section of this NOFO.
Total Funding
$50.0M
CFDA Number
93.912
Funding Instrument
Grant
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
October 15, 2021
Close Date
January 18, 2022
Posted Date
October 15, 2021
Eligible Applicant Types
Tags
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health